Kyorin Pharmaceuticals and Kyoto University explore cell therapy of pulmonary fibrosis

During a business results briefing, it was reported that Kyorin Pharmaceuticals is developing iPS cell-derived alveolar epithelial cells, jointly with Kyoto University, to explore drug discovery targets

Nikkei Biotech news release, May 19, 2017

Kyorin Pharmaceuticals and Kyoto University explore cell therapy of pulmonary fibrosis
Scroll to top